Inotiv, Inc. to Participate in Three Investor Conferences in November 2025

WEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in the upcoming UBS Global Healthcare Conference, the Jefferies Global Healthcare Conference in London, and the Craig-Hallum Alpha Select Conference.

Conference Details

Event: UBS Global Healthcare Conference
Location: Palm Beach Gardens, FL
Date: November 10 and 11, 2025
Event Format: 1-on-1 institutional investor meetings only
Company Participants: Robert Leasure Jr., President and CEO, and Beth Taylor, CFO

Event: Jefferies Global Healthcare Conference in London
Location: London, UK
Date and Presentation Time: November 18, 2025 at 4:00PM GMT/11:00AM ET
Event Format: Presentation and 1-on-1 meetings
Link to Webcast
Company Participant: Robert Leasure, Jr., President and CEO

Event: Craig-Hallum Alpha Select Conference
Location: New York, NY
Date: November 18, 2025
Event format: 1-on-1 institutional investor meetings only
Company Participant: Beth Taylor, CFO

To schedule a meeting at the conferences with Inotiv management, or for more conference information, please contact your institutional sales representative at each firm.

About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs and medical devices to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical research and development projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotiv.com/.